跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lactobacillus reuteri
首页
药物
Lactobacillus reuteri
Experimental
Biotech
Lactobacillus reuteri
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
UNII ID
9913I24QEE
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PROBIOTIC COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI STRAINS AND METHODS OF USE
EP 3921425 A1
申请人: ELANCO US INC
优先权: 2019
CN
EP
US
WO
6 件公开
LACTOBACILLUS REUTERI AND USE, COMPOSITION, DRUG AND FOOD THEREOF
US 2024197796 A1
申请人: WISBIOM BEIJING BIOTECHNOLOGY CO LTD
优先权: 2021
CN
US
WO
6 件公开
Lactobacillus reuteri
US 12180463 B2
申请人: PREC GROUP LIMITED
优先权: 2019
CN
US
3 件公开
NOVEL LACTOBACILLUS REUTERI STRAIN AND USE THEREOF
US 2023303965 A1
申请人: KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY
优先权: 2020
CN
US
2 件公开
PRE-CONDITIONING OF L. REUTERI
EP 4056053 A1
申请人: BIOGAIA AB
优先权: 2021
CN
EP
2 件公开
GOS PRE-CONDITIONING L. REUTERI AND GOS IN FINAL FORMULATION
EP 4056052 A1
申请人: BIOGAIA AB
优先权: 2021
CN
EP
2 件公开
Use of Lactobacillus reuteri Y7 strain for prevention or treatment of ocular diseases
US 20250099517 A1
申请人: HUANG HUI YU
优先权: 2023
CN
US
2 件公开
USE OF LACTOBACILLUS REUTERI AND/OR METABOLITE THEREOF
WO 2025218629 A1
申请人: TCI CO LTD
优先权: 2024
CN
WO
2 件公开
Lactobacillus reuteri useful as probiotics
US 7192581 B2
申请人: PROBIONIC CORP
优先权: 2001
US
2 件公开
Lactobacillus reuteri hollow micro-capsule and its preparing method
CN 101249109 B
申请人: UNIV HUAQIAO
优先权: 2008
CN
第 1 / 10 页
上一页
下一页
药物
反馈